GeneDx Holdings Corp. (WGS)
NMS · Healthcare · Diagnostics & Research
$51.80
-0.79%
Closing price as of 2026-06-08 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.43B
P/S (TTM)
3.2x
Exchange
NMS
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 102.7M | 116.7M | 121.0M | 102.3M |
| Gross Profit | 70.9M | 84.5M | 84.3M | 68.2M |
| Operating Income | 9.0M | -3.3M | -14.2M | -26.2M |
| Net Income | 10.8M | -7.6M | -17.7M | -63.3M |
| Diluted EPS | $0.36 | $-0.27 | $nan | $-2.16 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 234.7M | 202.6M | 305.4M | 427.5M |
| Gross Profit | -26.8M | 90.0M | 194.4M | 298.2M |
| Operating Income | -457.5M | -170.2M | -23.2M | -13.1M |
| Net Income | -549.0M | -175.8M | -52.3M | -21.0M |
| Diluted EPS | $-53.79 | $-7.23 | $-1.94 | $nan |